Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis - Yang, Hwai-I; Tseng, Tai-Chung; Liu, Jessica; Lee, Mei-Hsuan; Liu, Chun-Jen; Su, Tung-Hung; Batrla-Utermann, Richard; Chan, Henry Lik-Yuen; Kao, Jia-Horng; Chen, Chien-Jen (Clinical gastroenterology and hepatology, 2016)
Keywords: Adult; Aged; Carcinoma, Hepatocellular - diagnosis; DNA, Viral - blood; Female; Gastroenterology and Hepatology; Hepatitis B Surface Antigens - blood; Hepatitis B, Chronic - complications; Hepatitis B, Chronic - pathology; Hong Kong; Hospitals, University; Humans; Liver Cancer; Liver Cirrhosis - complications; Liver Cirrhosis - pathology; Male; Middle Aged; Prediction; Prognosis; Prognostic Tool; Prospective Studies; Risk Assessment; Risk Factor; Serum - chemistry; Taiwan; CI; Prediction; HBeAg; Prognostic Tool; ALT; AUROC; HBsAg; HCC; Liver Cancer; CUHK; REVEAL; REACH-B; Risk Factor; CHB; HBV; hepatitis B virus; alanine aminotransferase; Risk Estimation for Hepatocellular Carcinoma in Chronic Hepatitis B; hepatitis B e antigen; Chinese University of Hong Kong; Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer; hepatocellular carcinoma; chronic hepatitis B; area under the receiver operating characteristic; hepatitis B surface antigen; confidence interval